Literature DB >> 20816377

Angiotensin-receptor blockade, cancer, and concerns.

Peter A Meredith, Gordon T McInnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20816377     DOI： 10.1016/S1470-2045(10)70163-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.

Authors:  Chan Yoon; Hyun-Sik Yang; Inpyo Jeon; Yoosoo Chang; Sang Min Park
Journal:  CMAJ       Date:  2011-08-29       Impact factor: 8.262

Review 2.  A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.

Authors:  Helmy M Siragy
Journal:  Vasc Health Risk Manag       Date:  2011-05-19

3.  Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.

Authors:  Artavazd Tadevosyan; Eric J Maclaughlin; Vardan T Karamyan
Journal:  Patient Relat Outcome Meas       Date:  2011-01-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.